Healthcare provider profile · identity verified

Gabrielle Ann Schuerman, ARNP, ND

Nurse Practitioner · KEENE, NH · NPI 1437227469

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	390	111
Atorvastatin Calcium	Atorvastatin Calcium	388	110
Levothyroxine Sodium	Levothyroxine Sodium	286	69
Lisinopril	Lisinopril	236	69
Amlodipine Besylate	Amlodipine Besylate	193	51
Oxycodone Hcl	Oxycodone Hcl	191	25
Omeprazole	Omeprazole	182	59
Gabapentin	Gabapentin	163	49
Hydrochlorothiazide	Hydrochlorothiazide	147	47
Albuterol Sulfate Hfa	Albuterol Sulfate	135	45
Simvastatin	Simvastatin	124	32
Fluoxetine Hcl	Fluoxetine Hcl	123	33
Metoprolol Succinate	Metoprolol Succinate	114	36
Trazodone Hcl	Trazodone Hcl	108	36
Sertraline Hcl	Sertraline Hcl	104	28
Metformin Hcl Er	Metformin Hcl	99	29
Pantoprazole Sodium	Pantoprazole Sodium	90	30
Metformin Hcl	Metformin Hcl	86	24
Lorazepam	Lorazepam	78	17
Famotidine	Famotidine	74	19
Metoprolol Tartrate	Metoprolol Tartrate	72	20
Montelukast Sodium	Montelukast Sodium	71	12
Alendronate Sodium	Alendronate Sodium	68	23
Fluticasone Propionate	Fluticasone Propionate	68	29
Furosemide	Furosemide	68	23
Atenolol	Atenolol	67	14
Citalopram Hbr	Citalopram Hydrobromide	67	19
Pravastatin Sodium	Pravastatin Sodium	65	20
Ozempic	Semaglutide	61	15
Eliquis	Apixaban	60	15
Glimepiride	Glimepiride	59	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	14
Tamsulosin Hcl	Tamsulosin Hcl	49	17
Allopurinol	Allopurinol	48	14
Synthroid	Levothyroxine Sodium	44	14
Venlafaxine Hcl Er	Venlafaxine Hcl	44	14
Bupropion Xl	Bupropion Hcl	43	11
Tramadol Hcl	Tramadol Hcl	43	12
Meloxicam	Meloxicam	42	14
Paroxetine Hcl	Paroxetine Hcl	42	12
Duloxetine Hcl	Duloxetine Hcl	40	13
Spironolactone	Spironolactone	40	suppressed
Alprazolam	Alprazolam	39	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Buspirone Hcl	Buspirone Hcl	39	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	18
Amitriptyline Hcl	Amitriptyline Hcl	38	11
Hydroxyzine Hcl	Hydroxyzine Hcl	37	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Mirtazapine	Mirtazapine	34	15
Chlorthalidone	Chlorthalidone	33	suppressed
Prednisone	Prednisone	33	19
Rosuvastatin Calcium	Rosuvastatin Calcium	33	12
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	16
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Carvedilol	Carvedilol	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Klor-Con M20	Potassium Chloride	21	suppressed
Potassium Chloride	Potassium Chloride	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	13
Warfarin Sodium	Warfarin Sodium	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Baclofen	Baclofen	16	suppressed
Diazepam	Diazepam	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Aripiprazole	Aripiprazole	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Famciclovir	Famciclovir	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	13
Acyclovir	Acyclovir	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Methylphenidate Er	Methylphenidate Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Drospirenone-Ethinyl Estradiol	Ethinyl Estradiol/Drospirenone	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Finasteride	Finasteride	11	suppressed
Humulin N	Insulin Nph Human Isophane	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error